rs4984948

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022773.4(LMF1):​c.1685C>G​(p.Pro562Arg) variant causes a missense change. The variant allele was found at a frequency of 0.02 in 1,608,040 control chromosomes in the GnomAD database, including 1,477 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 225 hom., cov: 33)
Exomes 𝑓: 0.019 ( 1252 hom. )

Consequence

LMF1
NM_022773.4 missense

Scores

1
5
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.50

Publications

25 publications found
Variant links:
Genes affected
LMF1 (HGNC:14154): (lipase maturation factor 1) Involved in triglyceride metabolic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Implicated in familial lipase maturation factor 1 deficiency. [provided by Alliance of Genome Resources, Apr 2022]
LMF1 Gene-Disease associations (from GenCC):
  • lipase deficiency, combined
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017978847).
BP6
Variant 16-854551-G-C is Benign according to our data. Variant chr16-854551-G-C is described in ClinVar as Benign. ClinVar VariationId is 1277320.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LMF1NM_022773.4 linkc.1685C>G p.Pro562Arg missense_variant Exon 11 of 11 ENST00000262301.16 NP_073610.2 Q96S06-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LMF1ENST00000262301.16 linkc.1685C>G p.Pro562Arg missense_variant Exon 11 of 11 5 NM_022773.4 ENSP00000262301.12 Q96S06-1

Frequencies

GnomAD3 genomes
AF:
0.0261
AC:
3977
AN:
152166
Hom.:
222
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00799
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.127
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.0524
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00713
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.0468
AC:
11050
AN:
236352
AF XY:
0.0412
show subpopulations
Gnomad AFR exome
AF:
0.00605
Gnomad AMR exome
AF:
0.175
Gnomad ASJ exome
AF:
0.00747
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.0111
Gnomad NFE exome
AF:
0.00683
Gnomad OTH exome
AF:
0.0329
GnomAD4 exome
AF:
0.0193
AC:
28119
AN:
1455756
Hom.:
1252
Cov.:
31
AF XY:
0.0197
AC XY:
14250
AN XY:
724096
show subpopulations
African (AFR)
AF:
0.00667
AC:
223
AN:
33444
American (AMR)
AF:
0.168
AC:
7412
AN:
44084
Ashkenazi Jewish (ASJ)
AF:
0.00683
AC:
178
AN:
26046
East Asian (EAS)
AF:
0.129
AC:
5094
AN:
39560
South Asian (SAS)
AF:
0.0517
AC:
4430
AN:
85662
European-Finnish (FIN)
AF:
0.0106
AC:
529
AN:
49928
Middle Eastern (MID)
AF:
0.00486
AC:
28
AN:
5762
European-Non Finnish (NFE)
AF:
0.00807
AC:
8967
AN:
1111078
Other (OTH)
AF:
0.0209
AC:
1258
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1451
2902
4352
5803
7254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0262
AC:
3984
AN:
152284
Hom.:
225
Cov.:
33
AF XY:
0.0300
AC XY:
2231
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00796
AC:
331
AN:
41570
American (AMR)
AF:
0.128
AC:
1958
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.140
AC:
722
AN:
5160
South Asian (SAS)
AF:
0.0523
AC:
252
AN:
4820
European-Finnish (FIN)
AF:
0.0130
AC:
138
AN:
10630
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00713
AC:
485
AN:
68006
Other (OTH)
AF:
0.0294
AC:
62
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
187
375
562
750
937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00983
Hom.:
5
Bravo
AF:
0.0332
TwinsUK
AF:
0.00836
AC:
31
ALSPAC
AF:
0.00934
AC:
36
ESP6500AA
AF:
0.00615
AC:
24
ESP6500EA
AF:
0.00910
AC:
75
ExAC
AF:
0.0371
AC:
4454
Asia WGS
AF:
0.0760
AC:
264
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27108409, 22239554, 25817768, 30420299) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 22, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.27
T;.;.
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.54
T;T;T
MetaRNN
Benign
0.0018
T;T;T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.9
M;.;.
PhyloP100
4.5
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-2.8
D;D;D
REVEL
Benign
0.25
Sift
Benign
0.084
T;T;T
Sift4G
Benign
0.19
T;T;T
Polyphen
0.75
P;.;.
Vest4
0.19
MPC
0.10
ClinPred
0.032
T
GERP RS
4.4
Varity_R
0.30
gMVP
0.62
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4984948; hg19: chr16-904551; COSMIC: COSV51894821; API